HUT46215A - Process for production of synergetic medical combinations containing aselastine and teofillin or aselastine and beta-mimeticum - Google Patents

Process for production of synergetic medical combinations containing aselastine and teofillin or aselastine and beta-mimeticum

Info

Publication number
HUT46215A
HUT46215A HU88160A HU16088A HUT46215A HU T46215 A HUT46215 A HU T46215A HU 88160 A HU88160 A HU 88160A HU 16088 A HU16088 A HU 16088A HU T46215 A HUT46215 A HU T46215A
Authority
HU
Hungary
Prior art keywords
aselastine
beta
teofillin
mimeticum
production
Prior art date
Application number
HU88160A
Other languages
English (en)
Other versions
HU200925B (en
Inventor
Ute Achterrath-Tuckermann
Rudolf Aurich
Juergen Engel
Helmut Hettche
Axel Kleemann
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of HUT46215A publication Critical patent/HUT46215A/hu
Publication of HU200925B publication Critical patent/HU200925B/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Finger-Pressure Massage (AREA)
  • Footwear And Its Accessory, Manufacturing Method And Apparatuses (AREA)
  • Impact Printers (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Chemically Coating (AREA)
  • Electroplating And Plating Baths Therefor (AREA)
  • Dental Preparations (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HU88160A 1987-01-17 1988-01-15 Process for producing synergetic medicine combinations comprising azelastin and theophylline or azelastin and beta-mimetic HU200925B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3701287 1987-01-17

Publications (2)

Publication Number Publication Date
HUT46215A true HUT46215A (en) 1988-10-28
HU200925B HU200925B (en) 1990-09-28

Family

ID=6319014

Family Applications (1)

Application Number Title Priority Date Filing Date
HU88160A HU200925B (en) 1987-01-17 1988-01-15 Process for producing synergetic medicine combinations comprising azelastin and theophylline or azelastin and beta-mimetic

Country Status (15)

Country Link
US (1) US5068233A (hu)
EP (1) EP0277352B1 (hu)
JP (1) JPS63239221A (hu)
AT (1) ATE68347T1 (hu)
AU (1) AU603410B2 (hu)
CA (1) CA1314484C (hu)
DD (1) DD267187A5 (hu)
DE (1) DE3773893D1 (hu)
DK (1) DK18488A (hu)
ES (1) ES2051726T3 (hu)
GR (1) GR3002917T3 (hu)
HU (1) HU200925B (hu)
IE (1) IE60930B1 (hu)
NO (1) NO880174L (hu)
PT (1) PT86563B (hu)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2794021B2 (ja) * 1988-11-02 1998-09-03 エーザイ株式会社 アゼラスチン或いはその塩類含有経皮適用製剤
GB2284761A (en) * 1993-12-03 1995-06-21 Euro Celtique Sa Prophylactic treatment of asthma
AU2001296507A1 (en) * 2000-10-02 2002-04-15 Chiron Corporation Human anti-cd40 antibodies
GB2403655A (en) * 2003-07-11 2005-01-12 Cipla Ltd Combined pharmaceutical product comprising a beta-2 adrenoreceptor agonist & an antihistamine for treatment of respiratory diseases such as asthma
JP5094197B2 (ja) * 2006-04-27 2012-12-12 第一三共ヘルスケア株式会社 杯細胞過形成を抑制するための抗ヒスタミン剤含有医薬組成物
US11690849B2 (en) 2019-04-12 2023-07-04 LA PharmaTech Inc. Method of treating dementia
US11389458B2 (en) 2019-04-12 2022-07-19 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating parkinson's and huntington's disease
US11318144B2 (en) 2019-04-12 2022-05-03 LA PharmaTech Inc. Compositions and methods for treating Alzheimer's disease and Parkinson's disease
US11744833B2 (en) 2019-04-12 2023-09-05 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of insomnia
US10639314B1 (en) 2019-04-30 2020-05-05 LA PharmaTech Inc. Method of treating Alzheimer's disease
US11938139B2 (en) 2019-04-12 2024-03-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders
US10898493B2 (en) 2019-04-12 2021-01-26 LA PharmaTech Inc. Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease
US10966989B2 (en) 2019-04-12 2021-04-06 LA PharmaTech Inc. Pharmaceutical compositions and methods for treating mental, behavioral, cognitive disorders
US11351179B1 (en) 2021-08-05 2022-06-07 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of psychiatric disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE64051B1 (en) * 1987-11-13 1995-06-28 Asta Medica Ag Azelastine embonate process for its preparation and pharmaceutical preparations which contain azelastine embonate as active substance
ES2053678T3 (es) * 1987-11-13 1994-08-01 Asta Medica Ag Procedimiento para preparar un medicamento con contenido de azelastina para la aplicacion nasal y/u ocular.

Also Published As

Publication number Publication date
IE60930B1 (en) 1994-09-07
US5068233A (en) 1991-11-26
NO880174D0 (no) 1988-01-15
CA1314484C (en) 1993-03-16
EP0277352A1 (de) 1988-08-10
EP0277352B1 (de) 1991-10-16
NO880174L (no) 1988-07-18
GR3002917T3 (en) 1993-01-25
HU200925B (en) 1990-09-28
DE3773893D1 (de) 1991-11-21
PT86563A (de) 1988-02-01
ES2051726T3 (es) 1994-07-01
AU1029588A (en) 1988-07-21
IE880110L (en) 1988-07-17
PT86563B (pt) 1991-12-31
JPS63239221A (ja) 1988-10-05
DK18488A (da) 1988-07-18
DK18488D0 (da) 1988-01-15
DD267187A5 (de) 1989-04-26
ATE68347T1 (de) 1991-11-15
AU603410B2 (en) 1990-11-15

Similar Documents

Publication Publication Date Title
EP0302419A3 (en) Method and device for vapor sterilization of articles having lumens
IL86089A (en) Pharmaceutical compositions containing certain androstane-17-ones for the prophylaxis and therapy of retroviral infections
HUT46215A (en) Process for production of synergetic medical combinations containing aselastine and teofillin or aselastine and beta-mimeticum
GB2207035B (en) Apparatus for the treatment of seed
IN167609B (hu)
HUT48903A (en) Process for production of derivatives of adenosin and medical preparatives containing these substances
HUT47261A (en) Process for production of new tiasole-derivatives effecting on the cholinerg-system and medical compositions containing these substances
IE882391L (en) Pad printing process
HU893408D0 (en) Process for the production of glycosamino-glucane salts and medical preparations containing them
GB8423081D0 (en) Benzothiophene derivatives
IL86302A0 (en) Pharmaceutical combination for the prophylaxis and therapy of malaria
EP0313654A4 (en) MEDICINAL PRODUCTS FOR PROPHYLAXIS AND TREATMENT OF LIVER DISEASES.
GB2204488B (en) Pharmaceutical compositions for the treatment or prophylaxis of skin disorders
HU900666D0 (en) Process for preparing the way for elimination of articulational mistake on human jaw-bone and palate
GB8812533D0 (en) Instrument for surgical treatment of pieces of tissue
GR3005231T3 (hu)
HU905853D0 (en) Process for the preparation of medical products containing dopamine-autoreceptor-antagonists for treating drug dependence
GR880100613A (en) Medical device for gums treatment
IL84012A0 (en) Pharmaceutical composition for the treatment of high blood pressure
HUT49483A (en) Process for producing pharmaceutical composition for inhibiting or diminishing harm of blood platelets
ZA892712B (en) Oral pharmaceutical for the once-a-day treatment of hypertonia with diltiazem-hydrochloride
EP0349654A4 (en) Agent for prophylaxis and treatment of pancreatic disease or the like
IL81361A0 (en) Pharmaceutical preparation for treatment of hyperacidity in body fluids
GB8711392D0 (en) Vapour treatment of boards
GB8702406D0 (en) Instruments for administering liquids

Legal Events

Date Code Title Description
HMM4 Cancellation of final prot. due to non-payment of fee